News|Articles|November 18, 2025
Understanding Anti-Drug Antibody Assessment: Early Discovery through Clinical Trials
Author(s)Prolytix
Learn the unique considerations for use of ADA assays in early development, pre-clinical and clinical settings, as well as how to generate high-quality methods at each stage to support successful development and regulatory approval of safe and effective biotherapeutic drugs.
Related Content
Sponsored Content
Trending on Pharmaceutical Technology
1
PharmTech Explained: China's Biotech Rise Signals New Risks for US Manufacturers
2
A Capsule-in-Capsule Platform for Multi-Phase Release of Liquid and Solid Formulations
3
Andelyn Biosciences Partners with Queen's University on GM2 Gangliosidosis Gene Therapy
4
Dersimelagon Acquisition Highlights Shift Toward Late-Stage Rare Disease Licensing
5